Editas Medicine, Inc. (EDIT)
3.035
-0.14
(-4.41%)
USD |
NASDAQ |
May 07, 16:00
3.00
-0.04
(-1.15%)
After-Hours: 20:00
Editas Medicine SG&A Expense (TTM) : 36.53M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 2.715B |
| Puma Biotechnology, Inc. | 70.85M |
| Bristol Myers Squibb Co. | 7.30B |
| Black Diamond Therapeutics, Inc. | 16.57M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |